FinnCap reiterated their corporate rating on shares of Innovaderma (LON:IDP) in a research note published on Thursday.

LON IDP traded down GBX 6 ($0.08) on Thursday, hitting GBX 73.50 ($0.96). 155,150 shares of the stock traded hands, compared to its average volume of 81,503. Innovaderma has a twelve month low of GBX 117 ($1.53) and a twelve month high of GBX 410.50 ($5.36).

In other news, insider Joe Bayer acquired 3,100 shares of the business’s stock in a transaction on Friday, November 16th. The shares were purchased at an average price of GBX 85 ($1.11) per share, for a total transaction of £2,635 ($3,443.09).

Innovaderma Company Profile

InnovaDerma PLC, through its subsidiaries, engages in the research, manufacture, and marketing of clinically proven products in life sciences, beauty, and personal care products in Europe, the United States, Australasia, Asia, and Africa. It offers a range of men's skincare products, including hand and body washes, hand creams, face washes, and face moisturizers under the Charles + Lee name; and tailored solutions under the Leimo name for hair loss comprising shampoos, conditioners, and laser technology treatments developed to combat male and female hair loss, alopecia, thinning hair.

Read More: What is Net Asset Value (NAV)?

Receive News & Ratings for Innovaderma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innovaderma and related companies with MarketBeat.com's FREE daily email newsletter.